Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlencowe Resources Regulatory News (BRES)

Blencowe Resources PLC: Site for Downstream Processing Operations

Blencowe Resources PLC: Site for Downstream Processing Operations

Share Price Information for Blencowe Resources (BRES)

Share Price is delayed by 15 minutes
Get Live Data
7.50    0.10 (1.33%)
Bid:
7.30
Ask:
7.70
Spread: 0.40 (5.479%)
Market Cap: £37.42m
BRES Live PriceLast checked at - London Stock Exchange

Intraday Blencowe Resources Share Chart

Site for Downstream Processing Operations

Today 07:00

RNS Number : 1353K
Blencowe Resources PLC
29 June 2026
Β 

Date: 29 June 2026

Β 

Blencowe Resources Plc

("Blencowe" or the "Company")

Β 

Orom-Cross Secures Site for Downstream Processing Operations

Further De-risking for the Company's Graphite Beneficiation Strategy

Β 

Blencowe Resources Plc (LSE: BRES) is pleased to announce that it has selected the preferred siteΒ for the future downstream operations associated with its Orom-Cross Graphite Project in Uganda.

Following an extensive search and evaluation process, the Company has secured, by way of an option to purchase, a site of 100 acres located approximately 35km north of Gulu in Northern Uganda, as the future base for downstream processing operations to further beneficiate its graphite concentrate into purified products.

The agreed purchase price for the site is US$70,000, with a 30% down payment payable to secure the option. The option runs for an initial six-month period, with a further three-month extension available. The Company considers the cost to be modest and aligned with its staged downstream development strategy.

The infrastructure surrounding the site is particularly strong, with direct access to a large modern electrical substation connected to Uganda's hydroelectric power network, including generation from the Karuma Falls Hydropower Station, as well as access to a permanent water source. Downstream beneficiation requires reliable and cost-competitive energy, and the Company believes the selected location provides an optimal platform to support a low operating cost profile as downstream capacity is developed.

The scale of this site supports future anticipated growth as both Orom-Cross and the beneficiation facility ramp up together. Site selection is consistent with previously announced planned downstream development strategy and ongoing engineering work.

Β 

Highlights

Β· 100-acre site selected for downstream processing operations near Gulu, Northern Uganda

Β· Site secured by way of an option to purchase, with a total purchase price of US$70,000

Β· Site provides access to hydro-linked grid power and a permanent water source

Β· Planned facilities to support spheronised graphite and expandable graphite product pathways

Β· Supports Blencowe's strategy to move up the value chain beyond graphite concentrate sales

Β· Strengthens Uganda in-country beneficiation strategy and Western non-China graphite supply chain positioning

Β· ESIA and infrastructure costings now being progressed

Β 

The planned downstream facility is expected to support the Company's long-term strategy to move beyond graphite concentrate sales into higher-value upgraded graphite products, including spheronised graphite and expandable graphite. These product pathways form a central part of Blencowe's strategy to increase product optionality, improve realised pricing and position Orom-Cross within Western supply chains seeking scalable, non-China graphite supply.

Spheronisation is a key processing step used to shape graphite into spherical particles suitable for downstream battery-related applications, subject to further purification, coating, customer qualification and commercial requirements. Expandable graphite is used across a range of industrial, fire-retardant, thermal management and energy-related applications, and provides an additional higher-value product pathway for suitable flake material.

Β 

The Company believes the selected site offers several strategic advantages:

Β· Power: direct access to national grid infrastructure connected to Uganda's hydroelectric generation network

Β· Water: access to a permanent water source for downstream processing requirements

Β· Location: proximity to Gulu, supporting workforce, logistics (roads and rail) and regional infrastructure access

Β· Scale: 100 acres, providing space for phased expansion as downstream capacity is developed

Β· In-country value-add: supports Uganda's objective of increasing local beneficiation and industrial development

Β 

The downstream project is expected to include what the Company believes would be the first spheronisation/purification plant and expandable graphite processing facilities of their kind in Africa.

The Company is now progressing the Environmental and Social Impact Assessment (ESIA) for the site and confirming infrastructure costings.

Β 

Blencowe Resources Executive Chairman, Cameron Pearce commented:

"Securing a preferred downstream processing site near Gulu is an important step in Blencowe's strategy to build Orom-Cross into more than a conventional graphite concentrate project.

Our long-term objective is to capture more of the value chain in Uganda through the production of upgraded graphite products, including spheronised purified graphite and expandable graphite. The selected site provides access to key infrastructure, including hydro-linked power and water, and gives us the land footprint required to develop downstream capacity in phases as demand and commercial agreements progress.

This is strategically important for Blencowe, for Orom-Cross and for Uganda. In-country beneficiation has the potential to support higher-value product sales, local skills development, industrial growth and stronger alignment with Western markets actively seeking secure, scalable non-China graphite supply.

We are now progressing ESIA work and infrastructure costings for the site and will update the market as these workstreams advance."

Β 

For further information please contact:

Β 

Blencowe Resources Plc

www.blencoweresourcesplc.com

Β 

Sam Quinn (Director)

Tel: +44 (0)1624 681 250

info@blencoweresourcesplc.com

Β 

Sasha Sethi (Investor Relations)

Tel: +44 (0) 7891 677 441

sasha.sethi@blencoweresourcesplc.com

Tavira Financial (Joint Broker):

Β 

Jonathan Evans

Β 

Β 

Tel: +44 (0)20 3192 1733

jonathan.evans@tavira.group

Oak Securities (Joint Broker):

Β 

Calvin Man / Mungo Sheehan / Jerry Keen

Β 

Β 

Tel: +44 (0)20 3973 3678

Cavendish (Joint Broker):

Β 

Neil McDonald / Peter Lynch / Hanna Leijonmarck

Β 

Β 

Tel: +44 (0) 20 7908 6000

epr@cavendish.com

Twitter

Β 

https://twitter.com/BlencoweRes

LinkedIn

Β 

https://www.linkedin.com/company/72382491/admin/

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCEASKNADLKEEA
Date   Source Headline
23rd Jan 20237:00 amRNSAppointment of Leading Engineering Firm to DFS
16th Jan 20237:00 amRNSFinal Metallurgical Testing Programs
13th Jan 20237:00 amRNSAnnual Results 30 September 2022 & Notice of AGM
11th Jan 20234:40 pmRNSSecond Price Monitoring Extn
11th Jan 20234:35 pmRNSPrice Monitoring Extension
11th Jan 20237:00 amRNSExport Approval for Bulk Samples
6th Dec 20227:00 amRNSMetallurgical Test Work Update
17th Nov 20229:00 amRNSPrice Monitoring Extension
27th Oct 202211:10 amRNSIssue of Options
26th Oct 20227:00 amRNSStrategic Investment
24th Oct 20224:41 pmRNSSecond Price Monitoring Extn
24th Oct 20224:36 pmRNSPrice Monitoring Extension
6th Oct 202212:45 pmRNSWebinar Call
3rd Oct 20229:06 amRNSSecond Price Monitoring Extn
3rd Oct 20229:00 amRNSPrice Monitoring Extension
3rd Oct 20227:00 amRNSStrategic Party
27th Sep 202210:56 amRNSChange of Registered Office
26th Sep 20227:00 amRNSDFS Update
6th Sep 20227:00 amRNSAkelikongo Nickel Project Update
25th Jul 202210:00 amRNSInvestor Webinar
21st Jul 202210:00 amRNSResearch Note
19th Jul 20227:00 amRNSUpdated Corporate Presentation
19th Jul 20227:00 amRNSPre-Feasibility Study Results for Orom-Cross
23rd Jun 20227:00 amRNSHalf-year Report
6th Jun 20227:00 amRNSFinal Metallurgical Test Work Results
30th May 20227:00 amRNSAirborne EM Survey at Akelikongo
6th May 20222:09 pmRNSInvestor Evening
3rd May 20227:00 amRNSESG Consultants Appointed
26th Apr 20229:34 amRNSHolding(s) in Company
19th Apr 20221:43 pmRNSHolding(s) in Company
11th Apr 20227:30 amRNSPlacing
11th Apr 20227:30 amRNSUpdated Presentation
11th Apr 20227:00 amRNSUpdated JORC Resource
6th Apr 202210:30 amRNSInvestor Webinar Call
21st Mar 20227:00 amRNSAkelikongo Exploration Programme
8th Mar 20227:00 amRNSPFS Update
25th Feb 202211:00 amRNSInvestor Webinar Recording
23rd Feb 202210:34 amRNSResult of AGM
23rd Feb 20227:00 amRNSPresentation & Investor Webinar
22nd Feb 20227:00 amRNSAcquisition of Nickel Sulphide Project in Uganda
17th Feb 20227:00 amRNSRescheduling of Investor Webinar
16th Feb 20224:40 pmRNSSecond Price Monitoring Extn
16th Feb 20224:36 pmRNSPrice Monitoring Extension
10th Feb 20229:30 amRNSInvestor Call
8th Feb 20227:00 amRNSDrilling Results Northern Syncline
31st Jan 20223:32 pmRNSNotice of AGM
31st Jan 20227:00 amRNSCamp Lode Drilling Results
28th Jan 20227:00 amRNSAnnual Financial Report
26th Jan 20227:28 amRNSWork Programme
17th Jan 20222:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.